Àç¾i¥÷»P½Þ°¦§K¬Ì¤§Ãö«Y
¤@¡B«e¨¥
½Þ°¦¹ï§Ü¶Ç¬V©Ê¯e¯f¥Dn¬O¨Ì¿à¨ä§K¬Ì¨t²Î¤§§¹¾ã©Ê¡A¦b¬Æ¦h¼W±j§K¬Ì¤ÏÀ³ªº¦UºØ¦]¤l¤¤¡A¤é³¤¤Àç¾i¥÷³Ì©ö½Õ¸`¡C¦Ó½Þ°¦Àç¾i»Ýn¶q¤§µû¦ô«ü¼Ð¡A¤@¯ë§¡¥H½Þ°¦¥Íªø¡BÁc´Þ¤Î¥Í²£®Ä²v¬°¥D¡A¦¹¬°¸gÀÙ»P®Ä²v¤§¦Ò¶q¡C¦Ó¦¹¤@Àç¾i»Ýn¶q¬O§_¥i´£¨Ñ½Þ°¦³Ì¨Î§K¬Ì¤ÏÀ³¤§©Ò»Ý©O¡H¬Æ¦h¬ã¨s«ü¥X½Þ°¦³Ì¨Î¥Íªø¤ÏÀ³©Ò»Ý¤§Àç¾i¥÷¡A¨Ã¤£¨¬¥H´£¨Ñ³Ì¨Î§K¬Ì¤ÏÀ³¡C¦b²{¤µ¥ø·~¤Æ½Þ³õ¤¤¦UºØºò¢¦]¤l¡B¹}³¤¤¦³®`ª«½è¡A§¡ªýê½Þ°¦§K¬Ì¤O¤§µo®i¡A§Ü¯f¤O¦ÛµM§C¤U¡A¨ú¦Ó¥N¤§¬°§Ü¥Í¯À»PÁDÓi¾¯¤§¨Ï¥Î¡C¥B¦³¾ÇªÌ«ü¥X§Ü¥Í¯À¤§¥Íªø¼W±j¼Ò¦¡¡A¬O¥Ñ©ó°§C°Êª«¹ï§Üì©Ê±µÄ²¤Î¨¾¤î§K¬Ì²£ª«¤§²§¤Æ§@¥Î©ÒP¡A¦ýÂâ¨Ó®ø¶OªÌ¹ï¯b²£«~¤§½Ã¥Ín¨D¬Æ°ª¡AÃĪ«´Ý¯d°ÝÃD§ó¬O±Ó·P¡C¬O¬G¡A§Q¥Î¤é³¤¤Àç¾i¥÷½Õ¸`½Þ°¦§K¬Ì¤ÏÀ³¡A´£¤É§Ü¯f¤O¡A¥H´î¤Ö¥ÎÃÄÀ£¤O¡A¬O¦³«Ý±´°Q¤§½ÒÃD¡C
¤G¡B½Þ°¦§K¬Ì¨t²Î
÷¨Å°Êª«¤§§K¬Ì¨t²Î¬O¥Ñ¬Æ¦h°ª«×¥\¯à¤§²ÓM©Ò²Õ¦¨¡CÂǥѿW¥ß©Î¥æ¤¬§@¥Î¤è¦¡ºc¦¨ÄY±Kªº¨¾½Ã¨t²Î¡A¦Ó¦¹¤@¨t²Î°w¹ï¥i¯à¤Þ°_¦M®`ªº¥~¨Óª«½è(¥i¯à¬°²Óµß¡BìÂΡB¯f¬r©Î¨ä¥L¬r©Êª«½è)±N¤§¥h°£©Î±þ·À¡C§K¬Ì¨t²Î´XºØ¤èªk³B²z¥~¨Óª«½è(§Üì)¡A«D¯S²§©Ê§K¬Ì¤ÏÀ³(nonspecific immune response)¬O¨ä¤¤¤§¤@¡A¤SºÙ¬°§]¾½§@¥Î(phagocylosis)¬O¥Ñ©ó¨x¡BµÊ¡BªÍŦ¡B¦å²G¤Î¨ä¥L¾¹©xªº¥¨¾½²ÓM±N§Üì§]¤J¨Ã®ø¤Æ(Nockel¡A1986)¡C
¦¹¥~²O¤Ú²ÓM¥ç¬O§K¬Ì¨t²Î¤S«n¦¨û¡A²O¤Ú²ÓM¤S¥i¤À¬°B©MT²ÓM¨âºØ¡A¨ä¤À§Oºc¦¨§K¬Ì¨t²Î¤¤¨â¤j§@¥Î¡AºÙ¤§¬°Åé²G©Ê§K¬Ì(humoral immunity)¤Î²ÓM«P¦¨©Ê§K¬Ì(cell¢wmediated immune response)¡CB²ÓM¬O¥Ñ¸VÃþ·Æ¤óÅn(bursa of fabricus)©Î÷¨ÅÃþ¬Û·í¤§²Õ´¡A¥i¯à¬°°©Åè¡BL¨x©Î¸z¹D¬ÛÃö²O¤Ú²Õ´(GALT)¦¨¼ô¦Ó¨Ó¡A¸g¥Ñ§Ü쪺¨ë¿EB²ÓM¼W´Þ¨Ã¤À¤Æ¬°¼ß²ÓM²£¥Í¯S²§©Ê§ÜÅé¡A¦¹¬°Åé²G©Ê§K¬Ì¡A²Ä¤@¦¸±µÄ²®É¥DnIgM¡A²Ä¤G¦¸±µÄ²®É¥Ñ©ó°O¾Ð©Ê²ÓM(memory cell)ªºÃö«Y¡A¥Dn¬OIgG¡BIgA´£¨Ñ½Þ°¦¸ûªø´Áªº«OÅ@¦¹§Y¬°§K¬Ìª`®g¤Wªº¸É±jª`®g(Booster in¢wjection)¡C
¦ÓT²ÓM¬O¸g¥Ñ¦b¯Ý¸¢¦¨¼ô¦Ó¨Óªº²O¤Ú²ÓM¡Aºc¦¨²ÓM«P¦¨§K¬Ì¤ÏÀ³¡A¥Dn¦³¨âºØ«¬ºA¥]¬A²ÓM¬r±þ§@¥Î¤Î©µ¿ð©Ê¹L±Ó¤ÏÀ³¡C
¤T¡BÀç¾i¥÷´£¤É§K¬Ì¤ÏÀ³±`¥Î¤§µû¦ô¤èªk
(¤@)¥Ö½§¸~µÈ¤ÏÀ³
(¤G)µõ´Þì¨ë¿E²O¤Ú²ÓMÂ૬¤ÏÀ³
(¤T)¥¨¾½²ÓM¤§§]¾½¤Î±þµß§@¥Î
(¥|)§K¬Ì²ÓM¤§²ÓM¿E¯À¤Àªc¯à¤O
(¤)µ¹»P¯S©w§Üì¨ë¿E¡A´ú¨ä§ÜÅé¤O»ù²£¥Í±¡§Î
(¤»)¬y¦¡²ÓM»ö(Flow cytometry)´ú©wT²ÓM¦¸±Ú¸sӤΦUÃþ²ÓMÁ`¼Æ
¥|¡B½Õ¸`½Þ°¦§K¬Ì¯à¤O¤§Àç¾i¥÷
¬Æ¦h¬ã¨sµo²{¤é³¤¤¥]¬A¯à¶q¡B³J¥Õ½è¡BÄqª«½è©Îºû¥Í¯Àµ¥Àç¾i¥÷¯Ê¥F§¡·|¤Þ°_°Êª«§K¬Ì¤O¤U°(Miller¡A1985¡FSusama et al. 1993¡FBeisel¡A1982)¡C³o¤è±¤§¬ã¨s¤j¦h¶°¤¤¦b¤p¹«¡B¤Ï¯ìÃ~¤Î®a¸V¡A¦b½Þ°¦¤§¬ã¨s¤´¤£¦h¡C
(¤@)¯à¶q
¯à¶q¦b½Þ°¦§K¬Ì¤ÏÀ³¤W§êºt¤§¨¤¦â¤´¥¼©úÁA¡A¤£¹L¤w¦³³ø§i«ü¥X§N¼ö¹ï·s¥Í¥J½ÞÀò±oªì¨Åªº³Q°Ê§K¬Ì²y³J¥Õ¦³¶¡±µ¼vÅT¡A¥¿±`±¡§Î¤U§N·|¨Ï½Þ°¦±Ä¹¶q¼W¥[¡A¦Ó¼öºò¢®Éè¦n¬Û¤Ï¡C¦ý¦¹¤@±¡§Î¹ï·s¥Í¥J½Þ¨Ã«D¦p¦¹¡A¥J½Þ¥X¥Í®ÉÅ餺§K¬Ì²y³J¥Õ§t¶q«D±`§C¡A¦b§l§mªì¨Å«á¦å¤¤IgG¿@«×¥Ñ1mg¡þml¼W¥[¦Ü¬ù30mg¡þml¡CY¥J½Þ¥X¥Í«á§Y»P¥À½Þ¤À¶}¡A¨ä¦å¤¤§K¬Ì²y³J¥ÕÅãµÛ¤U°(Blecha and Kelley¡A1981a)¡A¦¹¤@µ²ªG¤D¬O´H§N¾ÉPªì¨ÅÄá¨ú¶q°§C©ÒP(Kelley et al. 1982)¡C¤@¯ë¦Ó¨¥¡A¹}®Æ±Ä¹¶q¹ï½Þ°¦§K¬Ì¤ÏÀ³ªºª½±µÃö«Y¤´¥¼ª¾¡A¥Ñ©ó¹}®Æ¥Ñ¨ä¥LÀç¾i¦]¤l¤§¯Ê¥F©Î¤£¥¿Å±`¾ÉP±Ä¹¶q¤U°¡A¬G¯à¶q¤§¯Ê¥F¦Ü¦óºØµ{«×¹ï§K¬Ì¤ÏÀ³¦³¼vÅT¡A¦³«Ý±´°Q¡C
(¤G)³J¥Õ½è
Austic et al(1991)«ü¥X¬°¨Ï®a¯b¹F³Ì¨Î¤§¯S²§©Ê§K¬Ì¤OªºÓi°ò»Ä»Ýn¶q¸û³Ì¨Î¥Íªø©Ò»Ý¤§Ói°ò»Ä¶q¬°°ª¡A¦ý¬O´£°ªÓi°ò»Ä¤ô·Ç«oµLªk¹F¨ì´£°ª§K¬Ì¤ÏÀ³¤§®ÄªG¡C
Crenshaw et al(1984)¤À§OÁý¥H½Þ°¦20¢H©M13.9¢H³J¥Õ½è¤é³¡A¦ý¦b¹ïSRBC¤§§ÜÅé¤ÏÀ³µLÅãµÛ®t²§¡C³J¥Õ½è¨Ó·½¥i¯à¬O¼vÅT§K¬Ì¤ÏÀ³®t²§ªº¤@Ó¦]¤l¡ABounous and Kongshavn(1982)µo²{Phenylalanine·|°§C§K¬Ì¤ÏÀ³¡CHeugten et al(1994)«ü¥X¨âºØ³J¥Õ½è§t¶q(¹ï·Ó²Õ¤Î°ª³J¥Õ½è²Õ&§C³J¥Õ½è²Õ)¹ï21¤éÄÖÂ÷¨Å½Þ¦³¸û®tªº§K¬Ì¤ÏÀ³¡A¥i¯à¦]phenylalanineÅãµÛ°ª©ó§C³J¥Õ½è²Õ©ÒP¡C¤]µo²{leucine°ª¶q²K¥[¥ç·|°§C§K¬Ì¤ÏÀ³¡A¬G¦Ò¼{¨ä¥LÓi°ò»Ä©ÎÓi°ò»Äªº¬Û¹ï¤ñ¨Ò¡A¹ï¹F¨ì³Ì¨Î§K¬Ì¤O¥i¯à¤]»á¬°«n(Gatnau et al. 1995)¡C
Kornegay et al(1993)Áý»PÂ÷¨Å½Þ¤TºØlysine¤ô·Ç(NRC¡ANRC+0.1¢H lysin NRC+0.2¢H lysine)¤Î¨âºØ¹}¨|±¿n(0.28¤Î0.14m2¡þ½Þ)¤Uµo²{lysine»P¹}¨|±¿n¶¡µL¥æ¤¬§@¥Î¡A¹}¨|±¿n¥ç¤£¼vÅT§ÜÅ骺²£¥Í¡A·í´£°ªlysine®É¥i¼W¥[¦¸¯Å§ÜÅé¤ÏÀ³(secondary immune response)¡CCook and Miller(1991)¤]»{¬°lysine¯Ê¥F·|¼vÅT§K¬Ì¤ÏÀ³¡C
·í¥~¨Ó§Üì¨ë¿E¥¨¾½²ÓM®É·|¨Ï±o¥NÁ²¾Âà(metabolic shift)¡A«P¨Ï¥¨¾½²ÓM²£¥ÍIL¢w1¤ÎTNF(Klasing. 1988)Å餺Àç¾i¥÷¦Û¥Íªø©Ò»Ý¤¤«·s¤À°t¡A¨ÃÅX¦V©ó´£¨Ñ§K¬Ì¥\¯à©Ò»Ý(Beisel. 1977)¡A¨Ã§Q¥Î¦Ù¦×³J¥Õ½è°¸ÑÄÀ¥XÓi°ò»Ä¡A¥Î¥H¦X¦¨¯à¶q¡A¦Ó³o¨Ç§ïÅÜ·N¨ýµÛ¨¾¬Ìª`®g©Î§Üì¨ë¿E®É¡AÀç¾i¥÷»Ýn¶q§Y¶·§ïÅÜ¡A¦ý¬O§_´£°ª³J¥Õ½è©Î®ò°ò»Ä¦b¼W±j§K¬Ì¤O¤§µ²ªG¨Ã¤£¤@P¡C
(¤T)¦h¤£¹¡©M¯×»Ä
¯×ªÕ°£´£¨Ñ¯à¶q¥~¡A¥¦¤]´£¨Ñ¥²¶·©Ê¯×ªÕ¡A¨Ã¥i°µ¬°²ÓM½¤²Õ¦¨¥÷¤Î20ºÒ¤Æ¦Xª«¨Ó·½ªº«eÅXª«(eicosanoids)¡G¦p«e¦C¸¢¯À(prostaglandin)»P¥Õ²m¤T¯À(leukotriene)¡Cªñ¨Óµo²{¯×ªÕ¤]¬O§K¬Ì¤ÏÀ³ªº«n¦]¤l¡G¥]¬AÅé²G§K¬Ì¤ÏÀ³©M²ÓM«P¦¨©Ê§K¬Ì¤ÏÀ³§¡¨ü¤é³¤¤¯×ªÕ¶q©M«¬ºAªº¼vÅT¡A¦ý¬ã¨s¤j¦h¥HÂû©M¹«¬°¥D¡A¨ä¼vÅT§K¬Ì¤ÏÀ³¾÷¨î¡A§@¦p¤U°Q½×¡C
¦h¤£¹¡©M¯×»Ä¤¤¥Hlinoleic acid¤Îlinolenic acid¥Nªí£s-6¤Î£s-3¦h¤£¹¡©M¯×»Ä(polyunsaturated fatty acid,PUFA)Å餺§¡¸gÃì¥[ªøú@(elongase)©M¥h¹¡©Mú@(desaturase)¤§§@¥Î¡C£s-3 PUFA³Ì«áÂàÅܬ°DHA(C22¡G6, docosahexaenoic acid)Àx¦s©óºë²ÓM¡B¸£¯«¸g¡B²´©M²ÓM¾Àµ¥²Õ´¡ADHA¥ç¬°ºû¥Í¯Àªº»²¦]¤l¡A¨ã¦³§Ü«e¦C¸¢¯À©M¥Õ²m¤T¯Àªº§@¥Î¡C£s-6 PUFA³Ì«áÂàÅܦ¨ªá¥Í²m¥|»Ä¨Ã¤À§O§Î¦¨«e¦C¸¢¯À(PGG2,PGH2,PGE2,PGF2a)©M¥Õ²m¤T¯À(LTA4,LTB4,C4,D4,E4)µ¥§K¬Ì§í¨îª«½è¡A¨ä¤¤¥HPGE2©MLTB4¦b§K¬Ì¤ÏÀ³§í¨î¤W³Ì¨ãÃöÁä©Ê¡C
¥Ø«e©Ò´£¥X¤§£s-3¼W±j§K¬Ì¤ÏÀ³¤§²z½×»{¬°¸g¥Ñ¡G(1)µ²ºc©Ê§ïÅÜ(structural alteration)¡G§ïÅܧK¬Ì¤ÏÀ³¹Lµ{¤¤»Ã¯À§@¥Îªº¯×½èÀô¹Ò¡C(2)¤Æ¾Ç´C¤¶®ÄÀ³(chemical mediation effect)¡G°Ñ»P§K¬Ì²y³J¥Õªº¤Æ¾Ç¦X¦¨¡AÄÀ©ñ¤Îµ²¦X¡C
Utermohlen et al (1986)«ü¥X¤é³¤¤¹L¦hªº£s-6 PUFA·|¼W¥[°Êª«Åé¹ï¯e¯fªº·P¨ü©Ê¡A¨äì¦]¦³¡G§ïÅÜEicosanoidsªº²£¥Í¡A§ïÅܲÓM½¤¬y°Ê©Ê¡A°§C§]¾½²ÓM¥\¯à¤Î¦]PUFA¦³¦p²M¼ä(detergent)§@¥Î¡A·|¯}Ãa®æÄõ¤ó¶§©Êµß²ÓM¾À¦Ó³y¦¨¦º¤`¡C¦ý®æÄõ¤ó³±©Êµß¦]¥~³ò¦³¯×¦hÁÞ(lipopolysaccharide)ªººc³y¥i©è§ÜPUFAªº§@¥Î¡A¨Ï±oÅ餺³±©Êµß¹L«×¥Íªø³o¨Çì¦]§¡P¨Ï°Êª«©ö²£¥Í¸z¹D·P¬V¡C
ªá¥Í²m¥|»Ä»PEicosanoidsªº²£¥Í¡GÅ餺ªá¥Í²m¥|»Ä¦³¨âÓ¨Ó·½¡A¤@¬°¨Ó¦Û¤é³¤¤¡F¥t¤@¬°¦ÛLinoleic acid¦X¦¨¦Ó¨Ó¡Cªá¥Í²m¥|»Ä§l¦¬«á§Ö³t¦aÀx¦s¦b²ÓM½¤¡A¥B¥Hà¤Æ§ÎºAÀx¦s¡C¬G¶È¤Ö¶qªºªá¥Í²m¥|»Ä¥i¦X¦¨«e¦C¸¢¯À¡A¦]¬°¾L¤Æªá¥Íªo»Ä¤£¯àÂà¤Æ¦¨«e¦C¸¢¯À¡C
ªá¥Í²m¥|»Ä¤j©è¥Hºc¦¨²ÓM½¤¤WªºÁC¯×½è(phospholipid)ªº²Õ¦¨¤À¤§¤@¡CÁC¯×½è¦s©ó§Z±_¡B¸A¤Y©MµÇ¤W¸¢¤¤¥i¦X¦¨Áx©T¾J¡C²ÓM½¤¤W¤§ÁC¯×½è¥i¸g¥ÑÁC¯×(membrane¢wassociated phospholipase)§@¥Î¡A¯S§O¬Ophospholipase A2¡AÄÀ¥X´åÂ÷ºAªá¥Íªo»Ä¡C¦A¤À§O¬°¸g¥Ñ¤GºØ®|¸ô§@¥Î§Î¦¨«e¦C¸¢¯À©M¥Õ²m¯À(leukotriene)¡C¨ä¤@¬°5-lipooxygenase§@¥Î§Î¦¨5-HPETE¡A¦¹¤Æ¦Xª«§t¦³¦@³m¤T²mµ²ºc¦Ó«á¦AÂàÅÜÅܦ¨LTA4¡A¦¹ª«½è¬Û·í¤£Ã©wÀH§YÂàÅܦ¨LTB4©Î§t¦³²¸îŪºLTC4¡BD4©ME4¡C¥t¤@¬°¸gÀô®ñ¤Æú@(cyclooxygonase)§@¥Î§Î¦¨¥HÀô¥³à¬®Ö¤ß¥B§t¦³¨âÓ°¼Ã쪺«e¦C¸¢¯À¡C
(¥|)ºû¥Í¯À
¬Æ¦hºû¥Í¯À§¡¨ã¦³§K¬Ì¤O¼W±j®ÄªG¡A¦b½Þ°¦¤è±¥Hºû¥Í¯ÀE¬ã¨s³Ì¦h¡Cºû¥Í¯ÀE¤@¯ë¼ôª¾¨ã¦³§Ü®ñ¤Æ§@¥Î¡A¥i¨¾¤î¯×½è²£¥Í²B¹L®ñ¤Æª«(hydroperoxide)¤Î©Î®ñl¥Í¦Û¥Ñ°ò(oxygen-derived free radical)¡A¦Û¥Ñ°ò¬°¤@¤À¤l¨ã¦³¥¼°t¹ï¤§¹q¤l¹ï¡A¬Û·í¬¡¼â¡A©ö»Pª«½è¤ÏÀ³¦Ó³y¦¨²ÓM¶Ë®`(Machlin and Bendich,1987)¡A²ÓM¤º¦³¤@¨Ç»Ã¯À¨t²Î¥i®ø°£¦Û¥Ñ°ò¶Ë®`¡A¦p¶W®ðª[¤Æú@(superoxide dimutase)¡BIJú@(catalase)©M¾¢®ò°ò²¸¹L®ñ¤Æú@(glutathione peroxidase, GSHpx)µ¥¡C¦Ó²ÓM¤º¤§ºû¥Í¯ÀC¡BE¡BA¤Î£]-carotene§¡¨ã¦³²M°£¦Û¥Ñ°ò(free radical scavenger)§@¥Î¡C¦Û¥Ñ°ò¥ç³y¦¨§K¬Ì²ÓM§¹¾ã©Ê³Q¯}Ãa¦ÓP§K¬Ì¤O¤U°¡A¬G§Ü®ñ¤Æª«½è¡A¤j©è¦Ó¨¥§¡¨ã¦³´£ª@§K¬Ì¤O¥\¯à¡C
Larsen and Tollersrad(1981)¤ÎJansen et al. (1988)¸ÕÅçµ²ªGÅã¥ÜÃB¥~²K¥[ºû¥Í¯ÀE¹ï¥À½Þ¤§¦h§Î®Ö¥Õ¦å²y¥\¯àµL¼vÅT¡CBonnette et al(1990)¥H¨âºØºû¥Í¯À¿@«×(11&220 IU¡þkg)Áý¤©Â÷¨Å¥J½Þ¡A·íºû¥Í¯ÀE¿@«×´£°ª®É¦å¤¤ºû¥Í¯ÀE¼W¥[¡A¦ý¥Íªø©Ê¯à¡B§K¬Ì¤ÏÀ³¤Î¹ï§ÜSRBC§ÜÅé¤O»ùµL¼vÅT¡C¦ýPeplowski et al (1981)«ü·í¤é³¤¤ºû¥Í¯ÀE¹F20¡ÑNRC¤ô·Ç®É¡A«o¥i´£°ª§ÜÅé¤O»ù¡C¦¹¤@µ²ªG¡A¥i¯à¬O¨Ï¥Î½Þ°¦ªì©l¤§¦å¤¤ºû¥Í¯ÀE¤ô·Ç®t²§©ÒP(0.20 & 0.041 mg¡þml)¡A¦¹¥~¥çÀ³¦Ò¼{¤é³¤¤Se¤ô·Ç¡CWuryastuti et al(1993)«üºÙºû¥Í¯ÀE 11 IU¡þkg¤£¨¬¥H²£¥Í³Ì¨Î§K¬Ì¤ÏÀ³©Ò»Ý¡A±ý¹F¼W¶i§K¬Ì¤O¡A¤é³¤¤¶·¦³ºû¥Í¯ÀE 60 IU¡þkg¡C¤£¹LNemec et al (1994)¥Hºû¥Í¯ÀE55¡B110¡B220 IU¡þkgÁý¤©÷¨Å½Þ¤ÎÃh¥¥½Þ¡Aµ²ªGªì¨Å¤Î¨Å¥Ä¤¤§K¬Ì²y³J¥Õ§t¶q¤Î§K¬Ì¤ÏÀ³µL¼W¶i®ÄªG¡C
(¤)Äqª«½è
Äqª«½è¤¤ÄÝÖ´¡BÅK¡B»É©M¾N¬ã¨s¸û¦h¡C¥HÖ´¡BÅK¬°¨Ò¡A»¡©ú¦p¤U¡C
Ö´¬°¾¢®ò°ò²¸¹L®ñ¤Æú@¤§²Õ¦¨¤À»Pºû¥Í¯ÀE¨ó¦P¥h°£Å餺²£¥Í¤§¦Û¥Ñ°ò¡AºûÅ@§K¬Ì²ÓM¥\¯à°·¥þ(Sheffy and Schultz, 1979)¡CÖ´¦bÅ餺¥i»Pcysteineµ²¦X²£¥Í¦UºØ³J¥Õ½èÖ´(selenoprotein)¤ÎGSHpx¡A©Î»P¦Ù¦×²Õ´¯S²§©Êµ²¦X¡A¨ä¾l¸gµÇŦ¥Ñ§¿±Æªn¡C¤@¯ë½\ª«¤Î»Ã¥ÀÖ´¤¤50¢HÖ´§eselenomethionine§Î¦¡¦s¦b¡CHayek et al. (1989)¥HÖ´¤Îºû¥Í¯ÀEª`®g¥À½Þ¤Î¥J½Þ¡Aªì¨Å¤Î¥J½Þ¦å²M¤¤IgM§¡¼W¥[¡A¸g14¤Ñ«áIgM¤ÎIgG¥ç¦³´£¤É®ÄªG¡C
ÅK¦b¤p¹«¤§¬ã¨sµo²{¨ä¦b²O¤Ú²ÓM§êºt¥\¯à©Ê¨¤¦â¡C¦¹¥~¡AÅK¥i¹w¨¾·s¥Í¥J½Þ³h¦å¤Î«P¶i¥Íªø¡A¤j³¡¤ÀÅK§¡»PÅKµ²¦X³J¥Õ(transferrin©Mlactoferrin)¡Aª`®gÅK¾¯¨Ï¥ÎÅK³J¥Õ§e¹¡©Mª¬ºA¡A¦ý¹L¶qªº¥¼µ²¦XÅK«o¥i¬°²Óµß§Q¥Î¦Ó«P¨äÁcl¡CKnight et al (1983)«ü¥X¥J½Þª`®g100©Î200 mgªº¸²µå¿}»EÅK¤@¦Ü¤T¤Ñ·|¨Ï¸z¹D¤¤¤j¸z±ìµß¥Íªø¥[³t¡C
¤¡Bµ²½×
ÂǥѩúÁA§K¬Ì¤ÏÀ³¦p¦ó¨üÀç¾i¥÷½Õ¸`¤§ª¾ÃÑ¡A§ÚÌ¥i¦]¦¹Àò±o´XºØ§Q¯q¡G
(¤@)¥i¼W±j¹ï§Ü¯fì·L¥Íª«¤§«OÅ@©Ê¨¾¿m¾÷¨î¡C
(¤G)¥iÂಾ¥À¯b§K¬Ì©Ê«OÅ@¦]¤l¦Ü¤l¥N¡C
(¤T)ÂǧK¬Ì¨t²Î¤§¼W¥[¹F¨ì±±¨î¥Í²z¹Lµ{¡C
(¥|)§K¬Ì²£ª«Âಾ¦Ü¯b²£«~¡A¥i¨Ñ°Ó·~µÑ¨ú¤Î«D¶Ç²Î©Ê§Q¥Î¡C
¬ã¨sµo²{§K¬Ì¤ÏÀ³¼W¥[¡A°£Àò±o¤Wz§Q¯q¥~¡A¤]¦³¥Íªø§í¨î®ÄªG¡C¨Ò¦p¡A¸g¥Ñ§K¬Ì¨ë¿E¥¨¾½²ÓM¤Àªc²ÓM¿E¯À(cytokines, IL¢w1)¡A¥i°§C¼W«¤Î¹}®Æ±Ä¹¶q¥B°©Àf¦Ù°¸Ñ²v´£°ª¡A¦X¦¨´î¤Ö¡C
Àç¾i¥÷¼W±j°Êª«§K¬Ì¤O¤§¼Ò¦¡¡A¦UºØ°Êª«¶¡¬Û¤¬§@¥Î¼Ò¦¡¥i¯à¤£¦P¡A¬GµLªk©ñ½Ñ¤Ñ¤U¦Ó¬Ò·Ç¡Cªp¥BÀç¾i¥÷¹L¶q©Î¤£¥¿Å¥ç¥i¯à¤Þµo¤Ï®ÄªG¡A¬GÀç¾i¥÷½Õ¸`½Þ°¦§K¬Ì¤ÏÀ³¤§¬ã¨s¤´¦³«Ý§V¤O¡CÁ`¤§¡A°£§Q¥Î§Ü¥Í¯À¨¾¤î½Þ°¦¯e¯f¤§¥~¡AÀç¾i§K¬Ì¾Ç´£¨Ñ¤F¥t¤@ºØ¼W±j½Þ°¦§K¬Ì¤O¤§ªÅ¶¡¡C
¹}®ÆÀç¾iÂø»x(p.59¡ã67)¢w¾G¥Ã²»¡B¤E¤C¦~¤Q´Á